Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$57K Sell
2,104
-2,556
-55% -$70.8K ﹤0.01% 6675
2014
Q2
$127K Buy
4,660
+3,654
+363% +$93.9K ﹤0.01% 5667
2014
Q1
$23K Buy
1,006
+177
+21% +$3.45K ﹤0.01% 7920
2013
Q4
$15K Sell
829
-2,849
-77% -$49.1K ﹤0.01% 8532
2013
Q3
$63K Buy
3,678
+3,159
+609% +$50.4K ﹤0.01% 6564
2013
Q2
$8K Buy
+519
New +$7.48K ﹤0.01% 8892

Other funds holding LDL

UBS's LDL Position: Q3 2014 in Review

UBS reduced its Lydall, Inc. (LDL) stake by 55% in Q3 2014, selling an estimated $70.8K and leaving 2,104 shares worth $57K. The position accounts for ﹤0.01% of the portfolio, ranked #6675.

UBS first reported a position in LDL in Q2 2013 and has held it in 6 quarters since. The position peaked at $127K in Q2 2014. 120 funds tracked by Wall St. Rank hold LDL as of Q3 2014.

  • UBS held 2,104 shares of Lydall, Inc. worth $57K as of Q3 2014.
  • UBS sold 2,556 Lydall, Inc. shares in Q3 2014, an estimated $70.8K.
  • Lydall, Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #6675 holding.
  • UBS first reported a position in Lydall, Inc. in Q2 2013 and has held it in 6 quarters since.
  • UBS's Lydall, Inc. position peaked at $127K in Q2 2014.
  • 120 funds tracked by Wall St. Rank held Lydall, Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.